
Oncology NEWS International
- Oncology NEWS International Vol 7 No 3
- Volume 7
- Issue 3
NCI’s Consumer Liaison Group Chooses Four Areas of Concern
BETHESDA, Md--The new consumer liaison group to the NCI director has chosen three of its 15 members to serve as co-chairs and has identified four areas of concern for its initial attention.
BETHESDA, Md--The new consumer liaison group to the NCI director has chosen three of its 15 members to serve as co-chairs and has identified four areas of concern for its initial attention.
The co-chairs are M. Venus Gines, a breast-cancer survivor from Lithonia, Ga, active in community work with the American Cancer Society; Susan A. Leigh of Tucson, Ariz, a survivor of Hodgkins disease, breast cancer, and bladder cancer, and active in the National Coalition for Cancer Survivorship and the Oncology Nursing Society; and Daniel M. Moore, Jr., a prostate cancer survivor from Decatur, Ill, who started the Central Illinois US TOO! prostate cancer support group.
The consumer groups four areas of immediate concern are communications and immediate access to reliable cancer information; informed consent, including making forms more understandable; patient consumer issues and population and genetics studies; and ways to identify additional consumer representatives for NCI committees and groups.
Articles in this issue
over 27 years ago
ACS Takes Aim at Proposed Federal Tobacco Billsover 27 years ago
Loan Defaults Disqualify 1,402over 27 years ago
FDA Gives OK to Seven New Cancer Drugs in 1997over 27 years ago
HIA Chemo Promising in Colon Cancer Liver Metsover 27 years ago
Proposed Budget Spells ‘Good News’ for NCIover 27 years ago
Proposed Budget Has Extra Funds for FDA Teen Smoking Effortover 27 years ago
CRFA Awards 16 New Grants and Fellowshipsover 27 years ago
Cancer Pain Treatment Requires Clear Terminology About ‘Addiction’over 27 years ago
‘Staging’ of the Managed Care Market Is Crucialover 27 years ago
NCI, EPA Attempt to Resolve Differences Over Childhood CancerNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.


















































































